Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Shares Outstanding (Weighted Average) (2024 - 2025)

Guardian Pharmacy Services' Shares Outstanding (Weighted Average) history spans 2 years, with the latest figure at $39.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 330.5% year-over-year to $39.4 million; the TTM value through Dec 2025 reached $39.4 million, up 330.5%, while the annual FY2025 figure was $39.4 million, 330.5% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $39.4 million at Guardian Pharmacy Services, up from $23.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $61.1 million in Q3 2024 and bottomed at $9.2 million in Q4 2024.